Maternal Methyl-Nutrient Status and Infant Neurodevelopment Study
2026年5月27日 更新者:Chi-Man Kuok、Far Eastern Memorial Hospital
Maternal Methyl-Nutrient Status During Pregnancy and Its Association With Infant Neurodevelopment: Exploring Potential Mechanisms
This prospective cohort study examines the relationship between maternal methyl-nutrient status during pregnancy and offspring neurodevelopment.
It integrates maternal dietary, biomarker, genetic, and microbiome data and follows children up to 24 months.
研究概览
详细说明
Evidence regarding the association between maternal methyl-nutrient status during pregnancy and offspring neurodevelopment remains inconsistent.
To address this gap, the present study is designed to comprehensively evaluate maternal methyl-nutrient status-specifically dietary intake and concentrations of choline, folate, betaine, and vitamin B12-at different gestational stages, and to examine their associations with infant and early childhood neurodevelopmental outcomes.
This prospective mother-child cohort will recruit pregnant women aged 20-45 years from the Department of Obstetrics and Gynecology at Far Eastern Memorial Hospital who are receiving routine prenatal care and intend to deliver at the study site.
At each trimester, maternal dietary intake will be assessed using a semi-quantitative food frequency questionnaire and three-day dietary records, accompanied by the collection of blood and stool specimens.
These samples will be analyzed for metabolic biomarkers (e.g., homocysteine, trimethylamine N-oxide [TMAO], and gut microbiota composition).
Furthermore, genetic polymorphisms in one-carbon metabolism-related genes (e.g., MTHFR, PEMT), maternal DNA methylation status, and the expression of neurodevelopment-related genes will be measured to investigate potential mechanistic pathways.
Infant outcomes will include neonatal anthropometrics (gestational age, birth weight, length, and head circumference) and longitudinal neurodevelopmental assessments at 6 months, 12 months, and 24 months using the Bayley Scales of Infant and Toddler Development.
In addition, meconium and cord blood samples at birth and stool samples during infancy will be collected for analysis.
By integrating multi-dimensional data on maternal nutrition, genetics, metabolism, and the gut microbiome, this study seeks to construct a comprehensive model linking maternal methyl-nutrient status during pregnancy with offspring neurodevelopment.
The findings are expected to inform evidence-based recommendations for optimal methyl-nutrient intake during pregnancy in Taiwan, thereby contributing to prenatal nutrition guidelines and early preventive strategies against developmental delays.
研究类型
观察性的
注册 (估计的)
240
联系人和位置
本节提供了进行研究的人员的详细联系信息,以及有关进行该研究的地点的信息。
学习联系方式
- 姓名:CHI MAN KUOK
- 电话号码:(+886) 952289592
- 邮箱:carmentoe@hotmail.com
学习地点
-
-
-
New Taipei City、台湾
- 招聘中
- Far Eastern Memorial Hospital
-
New Taipei City、台湾
- 尚未招聘
- Far Eastern Memorial Hospital
-
接触:
- Far Eastern Memorial Hospital
- 电话号码:+886 2 8966 7000
-
-
参与标准
研究人员寻找符合特定描述的人,称为资格标准。这些标准的一些例子是一个人的一般健康状况或先前的治疗。
资格标准
适合学习的年龄
- 孩子
- 成人
接受健康志愿者
是的
取样方法
非概率样本
研究人群
120 pregnant women and their 120 newborns/infants
描述
Inclusion Criteria for Pregnant Women
- Aged 20-45 years
- Singleton pregnancy
- Receiving routine prenatal care at the study site and planning to deliver at Far Eastern Memorial Hospital
Exclusion Criteria for Pregnant Women
- Diagnosed with major chronic diseases, including renal disease (defined as chronic kidney disease stage 3 or above or history of renal transplantation), liver disease (defined as liver cirrhosis or history of liver transplantation), or malignancy
- Alcohol consumption during pregnancy
- Diagnosed with eating disorders or psychiatric conditions that may impair the assessment of nutritional status
Inclusion Criteria for Newborns
● Newborns delivered by mothers who participate in this study
Exclusion Criteria for Newborns
- Diagnosed with congenital anomalies, epilepsy, or severe brain injury
- Inability to complete neurodevelopmental assessments at 6 months, 1 year, and 2 years of age at the study site
- Infants whose mothers are diagnosed with eating disorders or psychiatric conditions that may impair the assessment of nutritional status
学习计划
本节提供研究计划的详细信息,包括研究的设计方式和研究的衡量标准。
研究是如何设计的?
设计细节
队列和干预
团体/队列 |
|---|
|
FEMHPregnancy cohort
Throughout pregnancy, delivery, and infant follow-up at FEMH
|
研究衡量的是什么?
主要结果指标
结果测量 |
措施说明 |
大体时间 |
|---|---|---|
|
Maternal methyl-nutrient and other nutrition status
大体时间:From enrollment to delivery (approximately 9 months)
|
Maternal methyl-nutrient status will be assessed using the following measurements:
|
From enrollment to delivery (approximately 9 months)
|
|
Birth anthropometric measurements of the newborn
大体时间:At birth
|
This outcome will be assessed using medical records, including birth weight (grams), birth length (centimeters) , birth head circumference (centimeters), and gestational age at birth (weeks).
|
At birth
|
|
Infant neurodevelopmental outcomes
大体时间:At 6, 12, and 24 months of age
|
Infant neurodevelopment will be assessed using the Bayley Scales of Infant and Toddler Development, Fourth Edition (Bayley-IV), including composite scores for cognitive, language, motor and social-emotional domains
|
At 6, 12, and 24 months of age
|
次要结果测量
结果测量 |
措施说明 |
大体时间 |
|---|---|---|
|
Plasma homocysteine concentration
大体时间:During pregnancy (each trimester) and at birth (cord blood)
|
Plasma homocysteine levels (µmol/L) will be measured using standard enzymatic assays.
|
During pregnancy (each trimester) and at birth (cord blood)
|
|
Plasma trimethylamine N-oxide (TMAO) concentration
大体时间:During pregnancy (each trimester) and at birth (cord blood)
|
Plasma TMAO levels (ng/mL, µmol/L)will be measured using enzyme-linked immunosorbent assay (ELISA) kit.
|
During pregnancy (each trimester) and at birth (cord blood)
|
|
Global DNA methylation levels
大体时间:During pregnancy (each trimester) and at birth (cord blood)
|
DNA methylation status (%) will be assessed using LINE-1 methylation analysis
|
During pregnancy (each trimester) and at birth (cord blood)
|
|
Gut microbiota composition
大体时间:During pregnancy (each trimester), at birth (meconium), and at 4, 6, 12, and 24 months of age
|
Gut microbiota composition will be analyzed using 16S rRNA gene sequencing and reported as relative abundance and diversity indices
|
During pregnancy (each trimester), at birth (meconium), and at 4, 6, 12, and 24 months of age
|
|
Genetic polymorphisms related to methyl metabolism
大体时间:During pregnancy
|
Genetic polymorphisms (e.g., MTHFR, PEMT) will be assessed using genotyping methods and reported as genotype frequencies (%)
|
During pregnancy
|
|
Expression levels of neurodevelopment-related genes
大体时间:During pregnancy (each trimester) and at birth (cord blood)
|
Gene expression levels will be measured using RT-qPCR and report as relative expression levels
|
During pregnancy (each trimester) and at birth (cord blood)
|
其他结果措施
结果测量 |
措施说明 |
大体时间 |
|---|---|---|
|
Dietary intake and diet quality
大体时间:From enrollment through pregnancy to 4 months postpartum
|
Dietary intake will be assessed using a Food Frequency Questionnaire (FFQ) and 3-day dietary records, including assessment of nutrient intake (grams/day ,mg/day)and dietary patterns.
Diet quality will be derived from these data
|
From enrollment through pregnancy to 4 months postpartum
|
合作者和调查者
在这里您可以找到参与这项研究的人员和组织。
研究记录日期
这些日期跟踪向 ClinicalTrials.gov 提交研究记录和摘要结果的进度。研究记录和报告的结果由国家医学图书馆 (NLM) 审查,以确保它们在发布到公共网站之前符合特定的质量控制标准。
研究主要日期
学习开始 (实际的)
2026年5月27日
初级完成 (估计的)
2029年1月18日
研究完成 (估计的)
2029年1月18日
研究注册日期
首次提交
2026年4月20日
首先提交符合 QC 标准的
2026年4月28日
首次发布 (实际的)
2026年5月6日
研究记录更新
最后更新发布 (实际的)
2026年5月29日
上次提交的符合 QC 标准的更新
2026年5月27日
最后验证
2026年1月1日
更多信息
与本研究相关的术语
其他研究编号
- 114224-F
计划个人参与者数据 (IPD)
计划共享个人参与者数据 (IPD)?
不
药物和器械信息、研究文件
研究美国 FDA 监管的药品
不
研究美国 FDA 监管的设备产品
不
此信息直接从 clinicaltrials.gov 网站检索,没有任何更改。如果您有任何更改、删除或更新研究详细信息的请求,请联系 register@clinicaltrials.gov. clinicaltrials.gov 上实施更改,我们的网站上也会自动更新.